These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16521066)

  • 21. Botulinum toxin: from spasticity reliever to a neuromotor re-learning tool.
    Krishnan RV
    Int J Neurosci; 2005 Oct; 115(10):1451-67. PubMed ID: 16162450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology].
    Jeppesen LL; Dalager T; Meden P
    Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776
    [No Abstract]   [Full Text] [Related]  

  • 23. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spasticity. Physical therapy, preventive measures and treatment].
    Gay S; Egon G
    Ann Fr Anesth Reanim; 2005 Jun; 24(6):663-6. PubMed ID: 15950113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin should be first-line treatment for poststroke spasticity.
    Sheean G
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):359. PubMed ID: 19289475
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Dobkin BH; Landau WM; Sahrmann S; Thomas Thach W; Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736; author reply 737-8. PubMed ID: 19720984
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety considerations in the use of botulinum toxins in children with cerebral palsy.
    Apkon SD; Cassidy D
    PM R; 2010 Apr; 2(4):282-4. PubMed ID: 20430330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin A for the treatment of achalasia.
    Rodríguez Cruz E; Sheehan C; Fraiberg E; Hasan S
    Bol Asoc Med P R; 1997; 89(4-6):57-9. PubMed ID: 9284600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin for spasticity after stroke.
    Buitrago MM; Koolwijk I
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12530438
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin for treatment of spasticity in adults.
    Reichel G
    J Neurol; 2001 Apr; 248 Suppl 1():25-7. PubMed ID: 11357235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
    Albany K
    Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from FMRI.
    Diserens K; Ruegg D; Kleiser R; Hyde S; Perret N; Vuadens P; Fornari E; Vingerhoets F; Seitz RJ
    Neurorehabil Neural Repair; 2010 Oct; 24(8):753-62. PubMed ID: 20663964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin for spasticity after stroke.
    Dobkin BH
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12530439
    [No Abstract]   [Full Text] [Related]  

  • 37. [Botulinum toxin in the treatment of cerebral palsy: case conference].
    Nezu A; Takahashi Y
    No To Hattatsu; 2011 Mar; 43(2):136-8. PubMed ID: 21409836
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin in the management of spasticity in adults.
    Turner-Stokes L; Ward A
    Clin Med (Lond); 2002; 2(2):128-30. PubMed ID: 11991094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin in poststroke spasticity.
    Ozcakir S; Sivrioglu K
    Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.